Mirati Therapeutics Eulerpool News

Mirati Therapeutics Eulerpool News

Mirati Therapeutics Notizie Azioni

Mirati Therapeutics è seguito da molti giornalisti e investitori in tutto il mondo. Qui raccogliamo le più recenti notizie Mirati Therapeutics.

• 19 gennaio ·

  Seeking Alpha
  Mirati Therapeutics ticks higher amid Nasdaq delisting for sale to Bristol-Myers
• 12 gennaio ·

  Yahoo
  Insider Sell: EVP, Chief Commercial Officer Benjamin Hickey Sells Shares of Mirati Therapeutics Inc
• 12 gennaio ·

  GuruFocus
  Insider Sell: EVP, Chief Commercial Officer Benjamin Hickey Sells Shares of Mirati Therapeutics Inc
• 11 gennaio ·

  Yahoo
  Mirati (MRTX) Gets EU Nod for Krazati in KRAS-Mutated NSCLC
• 10 gennaio ·

  Yahoo
  European Commission Approves KRAZATI (adagrasib) as a Targeted Treatment Option for Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) with a KRASG12C Mutation
• 10 gennaio ·

  Seeking Alpha
  Mirati's Krazati gets EU conditional approval for lung cancer
• 10 gennaio ·

  Thefly.com
  Mirati Therapeutics receives conditional authorization for KRAZATI from EC
• 8 gennaio ·

  Seeking Alpha
  Bristol-Myers looking for smaller deals after 2023 shopping spree: report
• 7 gennaio ·

  SeekingAlpha
  Tango Therapeutics Must Produce Its Own Data To Justify Its Valuation
• 3 gennaio ·

  Thefly.com
  The biopharmaceuticals stocks to own in 2024, according to BofA